Clinical Trial

SCUBE Proteins in Polycystic Ovary Syndrome (IPSOS)

Study acronym: IPSOS
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 9, 2026 (before its estimated July 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
This study investigates circulating levels of SCUBE-1 and SCUBE-3 proteins in women with polycystic ovary syndrome (PCOS) compared with healthy controls. Differences between normoinsulinemic and hyperinsulinemic PCOS subgroups will be evaluated, as well as correlations with clinical and metabolic parameters related to inflammation and cardiovascular risk.
Trial Details
NCT Number NCT07396402
Lead Sponsor Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Conditions Polycystic Ovary Syndrome (PCOS), Insulin Resistance
Enrollment 56 participants
Start Date 2026-01-15
Primary Completion 2026-07-01 (estimated)
Study Completion 2026-07-01 (estimated)
Updated on ClinicalTrials.gov 2026-02-09